Resources from the same session
1535O - Cost and value of EMA-registered checkpoint inhibitors for solid tumours in the Netherlands
Presenter: Atse Huisman
Session: Proffered paper session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
1536O - Indication-specific pricing and weighted-average pricing: Estimated price and cost savings for cancer drugs
Presenter: Daniel Michaeli
Session: Proffered paper session: Policy and preventive strategies
Resources:
Abstract
Webcast
1537O - Value of immune checkpoint blockade (ICB) in microsatellite stable/mismatch repair proficient (MSS/pMMR) metastatic colorectal cancer (mCRC)
Presenter: Benjamin Geisler
Session: Proffered paper session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
Q&A
Session: Proffered paper session: Policy and preventive strategies
Resources:
Webcast
1538O - Environmental pollutants and molecular alterations in non-small cell lung cancer: Insights from the KBP-2020 cohort study
Presenter: Alexis Cortot
Session: Proffered paper session: Policy and preventive strategies
Resources:
Abstract
Slides
Webcast
Invited Discussant 1538O
Presenter: Suzette Delaloge
Session: Proffered paper session: Policy and preventive strategies
Resources:
Slides
Webcast
Q&A
Session: Proffered paper session: Policy and preventive strategies
Resources:
Webcast